15-KETO PROSTAGLANDIN E2
|
|
|
- CAS-Nr.
- 26441-05-4
- Englisch Name:
- 15-KETO PROSTAGLANDIN E2
- Synonyma:
- (Z)-7-((1R,2R,3R)-3-Hydroxy-5-oxo-2-((E)-3-oxooct-1-en-1-yl)cyclopentyl)hept-5-enoic acid;15-KetoPGE2;15-Oxoprostaglandin E2;15-KETO PROSTAGLANDIN E2;15-Dehydroprostaglandin E2;Dinoprostone EP Impurity F;15-keto Prostaglandin E2 MaxSpecStandard;Alprostadil (Prostaglandin E1) Impurity 6;Alprostadil (prostaglandin E1) Impurity 14;15-keto Prostaglandin E2 Lipid Maps MS Standard
- CBNumber:
- CB0125323
- Summenformel:
- C20H30O5
- Molgewicht:
- 350.45
- MOL-Datei:
- 26441-05-4.mol
|
15-KETO PROSTAGLANDIN E2 Eigenschaften
- Siedepunkt:
- 534.4±50.0 °C(Predicted)
- Dichte
- 1.144±0.06 g/cm3(Predicted)
- storage temp.
- −20°C
- L?slichkeit
- DMF: >100 mg/ml (from PGE2); DMSO: >100 mg/ml (from PGE2); Ethanol: >100 mg/ml (from PGE2); PBS pH 7.2: >5 mg/ml (from PGE2)
- Aggregatzustand
- A crystalline solid
- pka
- 4.75±0.10(Predicted)
- Farbe
- White to off-white
Sicherheit
15-KETO PROSTAGLANDIN E2 Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
15-keto Prostaglandin E2 (15-keto PGE2) is a metabolite of PGE2 formed by 15-hydroxy PGDH. In vivo, 15-keto PGE2 is essentially inactive. It has an attenuated affinity for the EP4 and EP2 receptors compared to PGE2 (Ki = 2,600-15,000 nM for the inhibition of PGE2 binding compared to a Kd = 1 nM for PGE2).[Cayman Chemical]
15-KETO PROSTAGLANDIN E2 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
15-KETO PROSTAGLANDIN E2 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 48)Lieferanten
- (E)-7-[(1R,2S,3R)-3-hydroxy-5-oxo-2-[(E)-3-oxooct-1-enyl]cyclopentyl]hept-5-enoic acid
- 11-Hydroxy-9,15-dioxo-[5Z,11α,13E]-prosta-5,13-dien-1-oic acid: 15-Dehydroprostaglandin E2
- (5Z,11R,13E)-11-Hydroxy-9,15-dioxoprosta-5,13-dien-1-oic acid
- (5Z,13E)-11α-Hydroxy-9,15-dioxo-5,13-prostadiene-1-oic acid
- (5Z,13E)-9,15-Dioxo-11α-hydroxyprosta-5,13-diene-1-oic acid
- 15-KetoPGE2
- 15-Oxoprostaglandin E2
- 15-keto Prostaglandin E2 Lipid Maps MS Standard
- 11-Hydroxy-9,15-dioxo-[5Z,11α,13E]-prosta-5,13-dien-1-oic acid
- 15-Dehydroprostaglandin E2
- 15-KETO PROSTAGLANDIN E2
- 9,15-DIOXO-11ALPHA-HYDROXY-PROSTA-5Z,13E-DIEN-1-OIC ACID
- 15-keto Prostaglandin E2 MaxSpecStandard
- Prosta-5,13-dien-1-oic acid, 11-hydroxy-9,15-dioxo-, (5Z,11α,13E)-
- Dinoprostone EP Impurity F
- (Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(E)-3-oxo-oct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid (15-oxo-PGE2
- Alprostadil (Prostaglandin E1) Impurity 6
- Alprostadil (prostaglandin E1) Impurity 14
- (Z)-7-((1R,2R,3R)-3-Hydroxy-5-oxo-2-((E)-3-oxooct-1-en-1-yl)cyclopentyl)hept-5-enoic acid
- 26441-05-4
